Quipt Home Medical (QIPT)
Market Price (3/16/2026): $3.65 | Market Cap: $159.2 MilSector: Health Care | Industry: Health Care Distributors
Quipt Home Medical (QIPT)
Market Price (3/16/2026): $3.65Market Cap: $159.2 MilSector: Health CareIndustry: Health Care Distributors
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 14%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 10% | Trading close to highsDist 52W High is 0.0% | Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -1.1 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -0.4% |
| Attractive yieldFCF Yield is 17% | Weak multi-year price returns2Y Excs Rtn is -47%, 3Y Excs Rtn is -115% | Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 66% |
| Megatrend and thematic driversMegatrends include Digital Health & Telemedicine, and Aging Population & Chronic Disease. Themes include Remote Patient Monitoring, and Geriatric Care. | Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -11% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 14%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 10% |
| Attractive yieldFCF Yield is 17% |
| Megatrend and thematic driversMegatrends include Digital Health & Telemedicine, and Aging Population & Chronic Disease. Themes include Remote Patient Monitoring, and Geriatric Care. |
| Trading close to highsDist 52W High is 0.0% |
| Weak multi-year price returns2Y Excs Rtn is -47%, 3Y Excs Rtn is -115% |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -1.1 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -0.4% |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 66% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -11% |
Qualitative Assessment
AI Analysis | Feedback
Quipt Home Medical (QIPT) stock has gained about 50% since 11/30/2025 because of the following key factors:
1. Acquisition Agreement at a Significant Premium.
Quipt Home Medical (QIPT) experienced a substantial gain due to the announcement on December 15, 2025, of a definitive agreement to be acquired by affiliates of Kingswood Capital Management and Forager Capital Management. Shareholders are set to receive US$3.65 per share in an all-cash transaction. This acquisition price represented a significant premium, including a 54% increase over the company's 30-day volume-weighted average price (VWAP) as of December 12, 2025.
2. Enhanced Shareholder Value Through Strategic Transaction.
The acquisition valued Quipt Home Medical at approximately US$260 million, including outstanding debt. The company's board of directors viewed this transaction as maximizing shareholder value by providing immediate liquidity and certainty of value. A special shareholder meeting was scheduled for March 3, 2026, to vote on the proposed transaction.
Show more
1. Acquisition Agreement at a Significant Premium.
Quipt Home Medical (QIPT) experienced a substantial gain due to the announcement on December 15, 2025, of a definitive agreement to be acquired by affiliates of Kingswood Capital Management and Forager Capital Management. Shareholders are set to receive US$3.65 per share in an all-cash transaction. This acquisition price represented a significant premium, including a 54% increase over the company's 30-day volume-weighted average price (VWAP) as of December 12, 2025.
2. Enhanced Shareholder Value Through Strategic Transaction.
The acquisition valued Quipt Home Medical at approximately US$260 million, including outstanding debt. The company's board of directors viewed this transaction as maximizing shareholder value by providing immediate liquidity and certainty of value. A special shareholder meeting was scheduled for March 3, 2026, to vote on the proposed transaction.
Show more
Stock Movement Drivers
Fundamental Drivers
The 49.6% change in QIPT stock from 11/30/2025 to 3/15/2026 was primarily driven by a 35.0% change in the company's P/S Multiple.| (LTM values as of) | 11302025 | 3152026 | Change |
|---|---|---|---|
| Stock Price ($) | 2.44 | 3.65 | 49.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 238 | 265 | 11.2% |
| P/S Multiple | 0.4 | 0.6 | 35.0% |
| Shares Outstanding (Mil) | 43 | 44 | -0.3% |
| Cumulative Contribution | 49.6% |
Market Drivers
11/30/2025 to 3/15/2026| Return | Correlation | |
|---|---|---|
| QIPT | 49.6% | |
| Market (SPY) | -3.1% | -4.5% |
| Sector (XLV) | -5.0% | 17.6% |
Fundamental Drivers
The 38.8% change in QIPT stock from 8/31/2025 to 3/15/2026 was primarily driven by a 25.3% change in the company's P/S Multiple.| (LTM values as of) | 8312025 | 3152026 | Change |
|---|---|---|---|
| Stock Price ($) | 2.63 | 3.65 | 38.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 238 | 265 | 11.2% |
| P/S Multiple | 0.5 | 0.6 | 25.3% |
| Shares Outstanding (Mil) | 43 | 44 | -0.3% |
| Cumulative Contribution | 38.8% |
Market Drivers
8/31/2025 to 3/15/2026| Return | Correlation | |
|---|---|---|
| QIPT | 38.8% | |
| Market (SPY) | 3.0% | 9.3% |
| Sector (XLV) | 9.5% | 14.6% |
Fundamental Drivers
The 38.3% change in QIPT stock from 2/28/2025 to 3/15/2026 was primarily driven by a 29.2% change in the company's P/S Multiple.| (LTM values as of) | 2282025 | 3152026 | Change |
|---|---|---|---|
| Stock Price ($) | 2.64 | 3.65 | 38.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 245 | 265 | 8.3% |
| P/S Multiple | 0.5 | 0.6 | 29.2% |
| Shares Outstanding (Mil) | 43 | 44 | -1.2% |
| Cumulative Contribution | 38.3% |
Market Drivers
2/28/2025 to 3/15/2026| Return | Correlation | |
|---|---|---|
| QIPT | 38.3% | |
| Market (SPY) | 12.4% | 13.2% |
| Sector (XLV) | 1.9% | 21.5% |
Fundamental Drivers
The -41.9% change in QIPT stock from 2/28/2023 to 3/15/2026 was primarily driven by a -59.4% change in the company's P/S Multiple.| (LTM values as of) | 2282023 | 3152026 | Change |
|---|---|---|---|
| Stock Price ($) | 6.28 | 3.65 | -41.9% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 151 | 265 | 75.3% |
| P/S Multiple | 1.5 | 0.6 | -59.4% |
| Shares Outstanding (Mil) | 36 | 44 | -18.4% |
| Cumulative Contribution | -41.9% |
Market Drivers
2/28/2023 to 3/15/2026| Return | Correlation | |
|---|---|---|
| QIPT | -41.9% | |
| Market (SPY) | 73.4% | 17.1% |
| Sector (XLV) | 23.3% | 20.4% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| QIPT Return | 740% | -16% | 8% | -40% | 16% | 3% | 445% |
| Peers Return | -20% | -27% | 29% | 23% | 20% | 11% | 24% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | -1% | 80% |
Monthly Win Rates [3] | |||||||
| QIPT Win Rate | 25% | 50% | 50% | 42% | 33% | 100% | |
| Peers Win Rate | 44% | 36% | 47% | 48% | 58% | 67% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 33% | |
Max Drawdowns [4] | |||||||
| QIPT Max Drawdown | 0% | -30% | -8% | -54% | -54% | 0% | |
| Peers Max Drawdown | -37% | -51% | -35% | -17% | -19% | -6% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -2% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: AHCO, VMD, RMD, EHAB, AVAH.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 3/13/2026 (YTD)
How Low Can It Go
| Event | QIPT | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -45.3% | -25.4% |
| % Gain to Breakeven | 83.0% | 34.1% |
| Time to Breakeven | 171 days | 464 days |
| 2018 Correction | ||
| % Loss | -18.0% | -19.8% |
| % Gain to Breakeven | 21.9% | 24.7% |
| Time to Breakeven | 524 days | 120 days |
Compare to AHCO, VMD, RMD, EHAB, AVAH
In The Past
Quipt Home Medical's stock fell -45.3% during the 2022 Inflation Shock from a high on 5/27/2021. A -45.3% loss requires a 83.0% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Quipt Home Medical (QIPT)
Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. In addition, it provides nebulizers, oxygen concentrators, CPAP and BiPAP units, ventilator equipment and aids, daily and ambulatory aides, equipment solutions, power wheelchairs, oxygen therapy, bariatric equipment, bathroom safety products, bilevel positive airway pressure, canes/crutches, continuous positive airway pressure, CPAP masks and accessories, hospital beds, humidifiers, compressors, patient lifts, walkers, products for wound care, and medical equipment for home-based sleep apnea and chronic obstructive pulmonary disease treatments, as well as rents respiratory equipment. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.
AI Analysis | Feedback
Here are 1-3 brief analogies for Quipt Home Medical (QIPT):
- Amazon for in-home medical equipment and supplies.
- Aaron's for essential home medical equipment.
AI Analysis | Feedback
- Durable Medical Equipment (DME): Provides a wide range of in-home medical equipment, including mobility aids, hospital beds, and bathroom safety products.
- Respiratory Therapy Equipment: Offers specialized equipment such as oxygen concentrators, CPAP/BiPAP units, and ventilators for respiratory and sleep disorders.
- Wound Care Products: Supplies products specifically designed for the treatment and management of various wounds.
- Chronic Disease Management Services: Provides comprehensive management services for patients dealing with chronic health conditions like heart and pulmonary disease or sleep disorders.
- Medical Equipment Rental: Offers rental services for a variety of medical equipment, particularly respiratory devices.
AI Analysis | Feedback
Quipt Home Medical Corp. (QIPT) primarily sells its medical equipment and services directly to individuals (patients) who require in-home care and support for various chronic health conditions. The company serves patients referred by physicians and other healthcare providers.
The major categories of customers (patients) Quipt Home Medical serves include:
- Patients with heart and pulmonary disease: This category includes individuals suffering from conditions such as Chronic Obstructive Pulmonary Disease (COPD) and other respiratory illnesses, who require equipment like oxygen concentrators, nebulizers, and ventilator equipment.
- Patients with sleep disorders: This segment comprises individuals diagnosed with sleep apnea and other sleep-related breathing disorders, for whom Quipt provides Continuous Positive Airway Pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units, masks, and accessories.
- Patients with reduced mobility and other chronic health conditions: This broad category includes individuals needing assistance with mobility (e.g., power wheelchairs, walkers, canes/crutches), bariatric equipment, bathroom safety products, hospital beds, patient lifts, and wound care products, often associated with various long-term health issues.
AI Analysis | Feedback
nullAI Analysis | Feedback
nullAI Analysis | Feedback
nullAI Analysis | Feedback
The emergence of digitally-native, direct-to-patient healthcare platforms that integrate medical equipment provision with chronic disease management. These platforms leverage advanced telehealth, remote monitoring, and direct logistics to offer a streamlined, integrated, and potentially lower-cost solution, challenging the traditional distribution and service model of companies like Quipt Home Medical.
AI Analysis | Feedback
nullAI Analysis | Feedback
nullAI Analysis | Feedback
nullLatest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| Quipt Home Medical Earnings Notes | 12/16/2025 |
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select ideas related to QIPT.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 02282026 | QDEL | QuidelOrtho | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 0.0% | 0.0% | 0.0% |
| 02272026 | CHE | Chemed | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 0.0% | 0.0% | 0.0% |
| 02272026 | LLY | Eli Lilly | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 0.0% | 0.0% | 0.0% |
| 02202026 | HAE | Haemonetics | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 3.5% | 3.5% | 0.0% |
| 02132026 | IQV | IQVIA | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 7.1% | 7.1% | -3.0% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 9.90 |
| Mkt Cap | 1.1 |
| Rev LTM | 1,675 |
| Op Inc LTM | 118 |
| FCF LTM | 74 |
| FCF 3Y Avg | 40 |
| CFO LTM | 80 |
| CFO 3Y Avg | 51 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 8.9% |
| Rev Chg 3Y Avg | 11.2% |
| Rev Chg Q | 16.6% |
| QoQ Delta Rev Chg LTM | 3.9% |
| Op Mgn LTM | 6.8% |
| Op Mgn 3Y Avg | 6.9% |
| QoQ Delta Op Mgn LTM | 0.3% |
| CFO/Rev LTM | 16.3% |
| CFO/Rev 3Y Avg | 16.1% |
| FCF/Rev LTM | 6.5% |
| FCF/Rev 3Y Avg | 5.7% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 1.1 |
| P/S | 0.6 |
| P/EBIT | 15.8 |
| P/E | 2.2 |
| P/CFO | 8.3 |
| Total Yield | 1.8% |
| Dividend Yield | 0.0% |
| FCF Yield 3Y Avg | 7.9% |
| D/E | 0.7 |
| Net D/E | 0.7 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 3.1% |
| 3M Rtn | 14.6% |
| 6M Rtn | 24.9% |
| 12M Rtn | 27.8% |
| 3Y Rtn | -4.6% |
| 1M Excs Rtn | 3.9% |
| 3M Excs Rtn | 15.8% |
| 6M Excs Rtn | 19.2% |
| 12M Excs Rtn | 13.6% |
| 3Y Excs Rtn | -70.7% |
Price Behavior
Price Behavior
| Market Price | $3.65 | |
| Market Cap ($ Bil) | 0.2 | |
| First Trading Date | 03/16/2018 | |
| Distance from 52W High | 0.0% | |
| 50 Days | 200 Days | |
| DMA Price | $3.59 | $2.69 |
| DMA Trend | up | up |
| Distance from DMA | 1.7% | 35.9% |
| 3M | 1YR | |
| Volatility | 4.6% | 86.5% |
| Downside Capture | -181.04 | -76.20 |
| Upside Capture | 3.70 | -16.09 |
| Correlation (SPY) | -4.6% | 12.4% |
QIPT Betas & Captures as of 2/28/2026
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | -0.05 | -0.08 | -0.36 | 0.50 | 0.59 | 0.73 |
| Up Beta | -0.21 | -0.16 | -0.20 | 0.81 | 0.72 | 0.70 |
| Down Beta | -0.07 | 0.01 | 1.56 | 2.06 | 1.77 | 1.23 |
| Up Capture | 9% | 0% | 16% | 25% | -7% | 12% |
| Bmk +ve Days | 9 | 20 | 31 | 70 | 142 | 431 |
| Stock +ve Days | 7 | 14 | 26 | 50 | 106 | 323 |
| Down Capture | -12% | -24% | -320% | -91% | -95% | 88% |
| Bmk -ve Days | 12 | 21 | 30 | 54 | 109 | 320 |
| Stock -ve Days | 4 | 10 | 15 | 49 | 110 | 368 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with QIPT | |
|---|---|---|---|---|
| QIPT | 56.1% | 86.2% | 0.85 | - |
| Sector ETF (XLV) | 5.0% | 17.5% | 0.12 | 21.3% |
| Equity (SPY) | 19.6% | 18.9% | 0.81 | 12.4% |
| Gold (GLD) | 71.9% | 26.3% | 2.05 | 2.9% |
| Commodities (DBC) | 19.3% | 17.3% | 0.89 | 4.7% |
| Real Estate (VNQ) | 6.2% | 16.3% | 0.19 | 18.8% |
| Bitcoin (BTCUSD) | -15.3% | 44.2% | -0.25 | 4.0% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with QIPT | |
|---|---|---|---|---|
| QIPT | -12.2% | 57.7% | -0.03 | - |
| Sector ETF (XLV) | 7.5% | 14.5% | 0.33 | 15.9% |
| Equity (SPY) | 13.1% | 17.0% | 0.61 | 16.1% |
| Gold (GLD) | 24.1% | 17.3% | 1.14 | 2.0% |
| Commodities (DBC) | 11.2% | 19.0% | 0.47 | 3.3% |
| Real Estate (VNQ) | 4.8% | 18.8% | 0.16 | 15.9% |
| Bitcoin (BTCUSD) | 6.3% | 56.7% | 0.33 | 6.9% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with QIPT | |
|---|---|---|---|---|
| QIPT | -9.5% | 58.5% | -0.13 | - |
| Sector ETF (XLV) | 10.1% | 16.5% | 0.50 | 14.7% |
| Equity (SPY) | 14.5% | 17.9% | 0.70 | 15.2% |
| Gold (GLD) | 14.4% | 15.6% | 0.77 | 0.6% |
| Commodities (DBC) | 8.6% | 17.6% | 0.40 | 5.0% |
| Real Estate (VNQ) | 5.6% | 20.7% | 0.23 | 14.4% |
| Bitcoin (BTCUSD) | 67.4% | 66.8% | 1.07 | 9.2% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 12/15/2025 | 34.1% | 34.9% | 37.9% |
| 8/11/2025 | -6.6% | 6.6% | 24.1% |
| 5/12/2025 | -21.6% | -34.5% | -0.5% |
| 12/16/2024 | -15.1% | -21.5% | -1.6% |
| SUMMARY STATS | |||
| # Positive | 1 | 2 | 2 |
| # Negative | 3 | 2 | 2 |
| Median Positive | 34.1% | 20.7% | 31.0% |
| Median Negative | -15.1% | -28.0% | -1.0% |
| Max Positive | 34.1% | 34.9% | 37.9% |
| Max Negative | -21.6% | -34.5% | -1.6% |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.